Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Works (20)

The IMF/NMA medical student mentorship program in health equity in multiple myeloma

Journal of the National Medical Association
2025-02 | Journal article
DOI: 10.1016/j.jnma.2025.01.001
Contributors: Manisha Bhutani; Semaje Testamark; Randall C. Morgan; Joseph Mikhael
Source: check_circle
Crossref

Down with dex!

Blood
2025-01-02 | Journal article
DOI: 10.1182/blood.2024026814
Contributors: Susan Harding; Joseph Mikhael
Source: check_circle
Crossref

Effects of Socioeconomic Status and Healthcare Resource Availability on Survival in Older (≥66 years) Non-Hispanic Black Patients Versus Non-Hispanic White Patients With Multiple Myeloma

Clinical Lymphoma Myeloma and Leukemia
2024-11 | Journal article
DOI: 10.1016/j.clml.2024.11.011
Contributors: Sophia S. Li; Robert Schuldt; Faiza Zafar; Tu My To; Archibong Yellow-Duke; Alina Levine; Allicia Girvan; Shelli Spence; Joseph Mikhael
Source: check_circle
Crossref

Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies

Blood Cancer Journal
2024-11-28 | Journal article
DOI: 10.1038/s41408-024-01149-w
Contributors: Paul G. Richardson; Aurore Perrot; Joseph Mikhael; Thomas Martin; Meral Beksac; Ivan Spicka; Marcelo Capra; Mattia D’Agostino; Pieter Sonneveld; Kamlesh Bisht et al.
Source: check_circle
Crossref

How can we stamp out high-risk myeloma?

Blood
2024-05-16 | Journal article
DOI: 10.1182/blood.2024024140
Contributors: Rahul Banerjee; Joseph R. Mikhael
Source: check_circle
Crossref

Addressing the disparities: the approach to the African American patient with multiple myeloma

Blood Cancer Journal
2023-12-18 | Journal article
DOI: 10.1038/s41408-023-00961-0
Contributors: Manisha Bhutani; Brandon J. Blue; Craig Cole; Ashraf Z. Badros; Saad Z. Usmani; Ajay K. Nooka; Leon Bernal-Mizrachi; Joseph Mikhael
Source: check_circle
Crossref

Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study

Blood Cancer Journal
2023-09-27 | Journal article
DOI: 10.1038/s41408-023-00923-6
Contributors: Thomas Martin; Meletios-Athanasios Dimopoulos; Joseph Mikhael; Kwee Yong; Marcelo Capra; Thierry Facon; Roman Hajek; Ivan Špička; Ross Baker; Kihyun Kim et al.
Source: check_circle
Crossref

Heart Failure Among Patients with Multiple Myeloma Treated with Carfilzomib-Based Versus Non–Carfilzomib-Based Regimens in the United States by Race

Clinical Lymphoma Myeloma and Leukemia
2023-08 | Journal article
DOI: 10.1016/j.clml.2023.04.009
Contributors: Shuling Li; Brandon T. Suehs; Alan Fu; Laura Sangaré; Chris Kim; Victor M. Gastanaga; Jiannong Liu; Heng Yan; Yihua Xu; Joseph Mikhael
Source: check_circle
Crossref

Disparities in multiple myeloma among African Americans

Journal of the National Medical Association
2023-05 | Journal article
DOI: 10.1016/j.jnma.2022.10.001
Contributors: Manisha Bhutani; Sagar Lonial; Joseph Mikhael
Source: check_circle
Crossref

Should I stay or should I go (to transplant)? Managing insufficient responses to induction in multiple myeloma

Blood Cancer Journal
2023-05-30 | Journal article
DOI: 10.1038/s41408-023-00864-0
Contributors: Rahul Banerjee; Louis Williams; Joseph R. Mikhael
Source: check_circle
Crossref

Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients

Blood Cancer Journal
2023-05-26 | Journal article
DOI: 10.1038/s41408-023-00856-0
Contributors: Rodrigo Fonseca; Mariano Arribas; Julia E. Wiedmeier-Nutor; Yael N. Kusne; Miguel González Vélez; Heidi E. Kosiorek; Richard J. Butterfield; Ilan R. Kirsch; Joseph R. Mikhael; A. Keith Stewart et al.
Source: check_circle
Crossref

Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study

Blood Cancer Journal
2023-05-09 | Journal article
DOI: 10.1038/s41408-023-00797-8
Contributors: Thomas Martin; Meletios-Athanasios Dimopoulos; Joseph Mikhael; Kwee Yong; Marcelo Capra; Thierry Facon; Roman Hajek; Ivan Špička; Ross Baker; Kihyun Kim et al.
Source: check_circle
Crossref

Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients

Blood Cancer Journal
2023-03-06 | Journal article
DOI: 10.1038/s41408-023-00794-x
Contributors: Rodrigo Fonseca; Mariano Arribas; Julia E. Wiedmeier-Nutor; Yael N. Kusne; Miguel González Vélez; Heidi E. Kosiorek; Richard J. Butterfield; Ilan R. Kirsch; Joseph R. Mikhael; A. Keith Stewart et al.
Source: check_circle
Crossref

Multiple Myeloma for the Primary Care Provider: A Practical Review to Promote Earlier Diagnosis Among Diverse Populations

The American Journal of Medicine
2023-01 | Journal article
DOI: 10.1016/j.amjmed.2022.08.030
Contributors: Joseph Mikhael; Manisha Bhutani; Craig E. Cole
Source: check_circle
Crossref

Multisite Quality Improvement Initiative to Identify and Address Racial Disparities and Deficiencies in Delivering Equitable, Patient-Centered Care for Multiple Myeloma—Exploring the Differences between Academic and Community Oncology Centers

Current Oncology
2023-01-25 | Journal article
DOI: 10.3390/curroncol30020123
Contributors: Joseph R. Mikhael; Shelby L. Sullivan; Jeffrey D. Carter; Cherilyn L. Heggen; Lindsay M. Gurska
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Chimeric Antigen Receptor T-Cell Therapies: Barriers and Solutions to Access

JCO Oncology Practice
2022-12 | Journal article
DOI: 10.1200/OP.22.00315
Contributors: Joseph Mikhael; Jessica Fowler; Nina Shah
Source: check_circle
Crossref

Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma

Blood Advances
2022-08-09 | Journal article
DOI: 10.1182/bloodadvances.2021006713
Contributors: Thomas Martin; Joseph Mikhael; Roman Hajek; Kihyun Kim; Kenshi Suzuki; Cyrille Hulin; Mamta Garg; Hang Quach; Hanlon Sia; Anup George et al.
Source: check_circle
Crossref

Digital Health for Patients With Multiple Myeloma: An Unmet Need

JCO Clinical Cancer Informatics
2021-12 | Journal article
DOI: 10.1200/CCI.20.00145
Contributors: Sundar Jagannath; Joseph Mikhael; Omar Nadeem; Noopur Raje
Source: check_circle
Crossref

Real-world renal function among patients with multiple myeloma in the United States

Blood Cancer Journal
2021-05-21 | Journal article
DOI: 10.1038/s41408-021-00492-6
Contributors: Joseph Mikhael; Erin Singh; Megan S. Rice
Source: check_circle
Crossref

Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score

American Journal of Hematology
2019-11 | Journal article
DOI: 10.1002/ajh.25603
Contributors: Kristen M. Sanfilippo; Suhong Luo; Tzu‐Fei Wang; Mark Fiala; Martin Schoen; Tanya M. Wildes; Joseph Mikhael; Nicole M. Kuderer; David C. Calverley; Jesse Keller et al.
Source: check_circle
Crossref

Peer review (9 reviews for 4 publications/grants)

Review activity for Blood cancer journal. (2)
Review activity for Clinical lymphoma, myeloma & leukemia. (4)
Review activity for Drugs (1)
Review activity for Targeted oncology. (2)
How many people are using ORCID?